Modification to Aeskulisa DS DNA G

FDA 510(k) K081251 · Aesku Diagnostics

Substantially Equivalent

510(k) numberK081251

Submission

Device name
Modification to Aeskulisa DS DNA G
Applicant
Aesku Diagnostics
Wendelsheim, Rheinland, DE
Received
May 2, 2008
Decision date
May 13, 2008
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA
Third-party review
Yes

Official FDA 510(k) record

Device classification

Product code
LSW – Anti-Dna Antibody, Antigen And Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5100
Specialty
Immunology

Other 510(k)s with product code LSW

510(k)DeviceApplicantDecision
K172348AESKUSLIDES nDNA (Crithidia luciliae), AESKUSLIDES nDNA (Crithidia luciliae) Demo Kit…LSW · Traditional Aesku.Diagnostics GmbH & Co. KG02/16/2018SE
K152013QUANTA Flash dsDNA, QUANTA Flash dsDNA Calibrators and QUANTA Flash dsDNA ControlsLSW · Traditional Inova Diagnostics, Inc.04/11/2016SE
K072393Elia Dsdna Immunoassay, Model 14-5500-01, Elia Ana Control, Model 83-1004-01LSW · Traditional Phadia US, Inc.12/07/2007SE
K060380Fidis DsdnaLSW · Traditional Biomedical Diagnostics (Bmd) SA05/02/2006SE
K041628Aeskulisa DS DNA GLSW · Traditional Aesku Diagnostics10/14/2004SE
K921658Anti-Dsdna Antibody TestLSW · Traditional Immco Diagnostics, Inc.03/22/1993SE
K872085The Gamma-B Anti-Ds DNA Kit & Optional ControlsLSW · Traditional Immunodiagnostics, Ltd.09/01/1987SE

More from Immunodiagnostics, Ltd.

510(k)DeviceDecision
K172461AESKUSLIDES ANCA Ethanol, AESKUSLIDES ANCA FormalinMOB · Traditional 03/23/2018SE
K172348AESKUSLIDES nDNA (Crithidia luciliae), AESKUSLIDES nDNA (Crithidia luciliae) Demo Kit…LSW · Traditional 02/16/2018SE
K132082Aeskulisa Dgp-A, Aeskulisa Dgp-G,Aeskulisa Dgp-CheckMST · Traditional 12/05/2013SE
K120889Aeskuslides Ana HEP-2DHN · Traditional 10/15/2012SE
K091859Aesku PR3MOB · Traditional 06/03/2010SE
K091860Aeskulisa Mpo, Model 30-7303USMOB · Traditional 02/23/2010SE
K081104Aeskulisa Ana HEP-2, Ref 30-7115USLKJ · Traditional 05/02/2008SE
K052439Aeskulisa Glia a and Aeskulisa Glia GMST · Traditional 02/07/2006SE
K041628Aeskulisa DS DNA GLSW · Traditional 10/14/2004SE
K041753Aeskulisa Ena 6 SLLL · Traditional 07/14/2004SE

Questions and answers

When was Modification to Aeskulisa DS DNA G cleared by the FDA?

Modification to Aeskulisa DS DNA G (K081251) received a 510(k) decision of Substantially Equivalent on May 13, 2008, 11 days after the submission was received.

What is the product code of K081251?

The FDA product code is LSW – Anti-Dna Antibody, Antigen And Control, a Class II (moderate risk) device regulated under 21 CFR 866.5100.